Article
Teva to pay $225 mln, divest cholesterol drug to settle price-fixing charges
Rating:
0.0
Views:
102
Likes:
1
Library:
1
Teva Pharmaceutical will pay $225 million and divest its copycat version of a cholesterol drug as part of its settlement of price-fixing charges, the U.S. Department of Justice said on Monday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value